Evidence map›Paper›PMID 42062911›Full record

ArticleBMC cardiovascular disorders2026

Empowering atrial fibrillation detection with TabPFN and SHAP interpretation based on ECG-derived features: a dual-center temporal validation study.

Mingming Chen, Tenglong Li, Zihan Wang, Xiaojue Fan, Haoming Xu, Yafeng Zhou, Min Hu

Abstract readValidation StudyMulticenter StudyComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mingming Chen *Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, 111 Ren'ai Road, Suzhou, Jiangsu, P.R. China.
Tenglong Li *Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, 111 Ren'ai Road, Suzhou, Jiangsu, P.R. China.
Zihan WangAcademy of Pharmacy, Xi'an Jiaotong-Liverpool University, 111 Ren'ai Road, Suzhou, Jiangsu, P.R. China.
Xiaojue FanCardiovascular Medicine, Suzhou Traditional Chinese and Western Medicine Hospital, No. 39, Xiashatang, Mudu Town, Wuzhong District, Suzhou, Jiangsu, P.R. China.
Haoming XuCardiovascular Medicine, The fourth affiliated hospital of soochow university, No. 9, Chongwen Road, Suzhou, Jiangsu, P.R. China.
Yafeng ZhouCardiovascular Medicine, The fourth affiliated hospital of soochow university, No. 9, Chongwen Road, Suzhou, Jiangsu, P.R. China.
Min HuCardiovascular Medicine, The Fourth Affiliated Hospital of Soochow University, Chongwen Road No. 9, Suzhou, Jiangsu Province, 215000, China. humin_ff1998@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) remains a leading driver of stroke and heart failure, yet timely diagnosis is frequently hindered by its asymptomatic nature and the limitations of current screening methods. This study aimed to develop and validate a highly accurate, interpretable, and scalable machine learning (ML) framework-TabPFN-for AF detection using standard 12-lead electrocardiogram (ECG)-derived features. To this end, we conducted a dual-center temporal validation study utilizing 248,324 ECG records across three distinct datasets: an internal cohort (n = 220,327), an external validation cohort (n = 6,181), and a temporal validation cohort (n = 21,816). The TabPFN model was trained on 12 clinical ECG features, such as PR interval, Paxis, and QTc, and compared against eight other ML architectures, including ensemble learning and neural networks. Model interpretability was established using SHAP (SHapley Additive exPlanations) to quantify feature contributions, and the framework was deployed via a web-based clinical interface. Results indicated that the TabPFN model demonstrated superior diagnostic efficacy, achieving an area under the receiver operating characteristic curve (AUROC) of 0.9711 in the internal cohort, 0.9797 in the external cohort, and 0.9766 in the temporal validation cohort. It outperformed traditional logistic regression (AUC 0.8687) and maintained a remarkably low Brier score (0.0474), indicating excellent calibration. Furthermore, SHAP analysis identified the PR interval and Paxis as the primary diagnostic drivers, revealing non-linear associations and physiological "inflection points" for AF presence, while decision curve analysis confirmed a high net benefit for clinical screening across all cohorts. In conclusion, by leveraging a Prior-Data Fitted approach (TabPFN) on standardized ECG features, we established a robust framework that matches the performance of complex deep-learning models while maintaining high interpretability and computational efficiency. This scalable tool, accessible via a web-based platform, bridges the gap between "black-box" AI and clinical practice, offering a practical solution for population-wide AF screening and the reduction of cardiovascular morbidity.

Indexed as

Action PotentialsAtrial FibrillationDiagnosis, Computer-AssistedElectrocardiographyHeart RateNeural Networks, ComputerSignal Processing, Computer-AssistedAgedDatabases, FactualFemaleHumansMaleMiddle AgedPredictive Learning ModelsPredictive Value of TestsReproducibility of ResultsAtrial fibrillationAutomated detectionElectrocardiogram (ECG) featuresMachine learning (ML)SHAPTabPFN

Identifiers

PMID42062911
PMCPMC13285071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.